Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The rule could impact more than 1.7 million TennCare enrollees statewide, making Tennessee part of a growing number of states reevaluating how obesity is treated under Medicaid programs
We maintain an Approved Supplier List with ongoing oversight
Injection site reactions, redness, swelling, or itching at the injection point, occur in a minority of users and are typically mild and transient
Smaller portions
Common Digestive Symptoms Shared by Both Medications Nausea Nausea is one of the most common complaints for both semaglutide and tirzepatide users, especially during dose escalation
US$ 23.27
US$ 21.70
US$ 21.69
US$ 27.50
US$ 24.63
US$ 25.70
US$ 24.02
US$ 22.85
US$ 25.50
